NCR3LG1 and cancer: However, as clinically observed, most of the human tumors are found to be B7-H6+ rather than B7-H6−, which suggests the functional compromise of the B7-H6 ligand-NKp30 receptor system in cancer patients to permit the growth of B7-H6+ tumor cells (33).